Company Search:
Advanced Search
Sponsored Links
Ipsen SA Company Snapshot
Ipsen SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ipsen SA with three other companies in this sector in France: Guerbet SA (2015 sales of 488.74 million Euro [US$536.48 million] of which 43% was X-rays), Boiron SA (607.80 million Euro [US$667.18 million] of which 51% was Non-Proprietary Homeopathic Medicines), and Virbac (852.62 million Euro [US$935.92 million] of which 56% was Companion Animals).

Sales Analysis. Ipsen SA reported sales of 1.52 billion Euro (US$1.67 billion) for the year ending December of 2015. This represents an increase of 14.1% versus 2014, when the company's sales were 1.33 billion Euro. Sales at Ipsen SA have increased during each of the previous five years (and since 2010, sales have increased a total of 38%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ipsen SA
  Stock Performance Chart for Ipsen SA
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 63.37
(Figures in Euro)
1 Week 0.2%   13 Weeks 4.2%  
4 Weeks 14.4%   52 Weeks 14.8%  
Ipsen SA Key Data:
  Ticker: IPN Country: France
  Exchanges: FRA LON PAR OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 1,520,200,000
(Year Ending Jan 2016).
Employees: 4,635
  Currency: Euro Market Cap: 5,210,318,915
  Fiscal Yr Ends: December Shares Outstanding: 82,220,592
  Share Type: Action Ordinaries Closely Held Shares: 47,409,958
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.